J. Whitaker
Chief Tech/Sci/R&D Officer en OMEROS CORPORATION .
Perfil
J.
Steven Whitaker is Vice President-Clinical Development at Omeros Corp.
In his past career Dr. Whitaker occupied the position of Chief Medical Officer & VP-Clinical Development at Allon Therapeutics, Inc. and Divisional Vice President at ICOS Corp.
Dr. Whitaker received a graduate degree from the University of Washington, an undergraduate degree from Butler University and a doctorate from The Indiana University School of Medicine.
Cargos activos de J. Whitaker
Empresas | Cargo | Inicio |
---|---|---|
OMEROS CORPORATION | Chief Tech/Sci/R&D Officer | 01/11/2019 |
Antiguos cargos conocidos de J. Whitaker.
Empresas | Cargo | Fin |
---|---|---|
ALLON THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/03/2010 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 01/05/2007 |
Formación de J. Whitaker.
University of Washington | Graduate Degree |
Butler University | Undergraduate Degree |
The Indiana University School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
OMEROS CORPORATION | Health Technology |
ALLON THERAPEUTICS INC. | Health Technology |
Empresas privadas | 1 |
---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |